{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:03:59Z","timestamp":1787162639601,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-04027-8","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:01:07Z","timestamp":1764943267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case series and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiaqi","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"4027_CR1","unstructured":"Global Strategy for Prevention. Diagnosis and Management of COPD: 2025 [EB\/OL] (2024-12-16). https:\/\/goldcopd.org\/2025-gold-report\/."},{"key":"4027_CR2","doi-asserted-by":"crossref","unstructured":"Bafadhel M, McKenna S, Agbetile J et al. Aspergillus fumigatus during stable state and exacerbations of COPD [J]. Eur respir J. 2014;43(1):64\u201371.","DOI":"10.1183\/09031936.00162912"},{"key":"4027_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/lungindia.lungindia_449_24","volume":"42","author":"G Singh","year":"2025","unstructured":"Singh G, Hanumanthappa MK, Agarwal R, et al. Prevalence of Aspergillus colonization and sensitization in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. Lung India. 2025;42:61\u20134.","journal-title":"Lung India"},{"key":"4027_CR4","doi-asserted-by":"crossref","unstructured":"Otu A, Kosmidis C, Mathioudakis AG et al. The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease [J]. Infection. 2023;51(4):813\u201329.","DOI":"10.1007\/s15010-022-01960-2"},{"key":"4027_CR5","doi-asserted-by":"crossref","unstructured":"Agarwal R, Sehgal IS, Muthu V et al. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses [J]. Eur Respir J. 2024;63(4):2400061.","DOI":"10.1183\/13993003.00061-2024"},{"key":"4027_CR6","doi-asserted-by":"crossref","unstructured":"Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease [J]. Mycoses. 2008;51(1):83\u20135.","DOI":"10.1111\/j.1439-0507.2007.01432.x"},{"key":"4027_CR7","doi-asserted-by":"crossref","unstructured":"Zhang P, Ma Y, Chen X et al. The difference in All-Cause mortality between allergic bronchopulmonary aspergillosis with and without chronic obstructive pulmonary disease [J]. J asthma allergy. 2022;15:1861\u201375.","DOI":"10.2147\/JAA.S389985"},{"key":"4027_CR8","doi-asserted-by":"crossref","unstructured":"Barnes PJ. Inflammatory endotypes in COPD [J]. Allergy. 2019;74(7):1249\u201356.","DOI":"10.1111\/all.13760"},{"key":"4027_CR9","first-page":"2650","volume":"97","author":"AG Society","year":"2017","unstructured":"Society AG, o C T. Expert consensus on the diagnosis and treatment of allergic bronchopulmonary aspergillosis [J]. Natl Med J China. 2017;97:2650\u20136.","journal-title":"Natl Med J China"},{"key":"4027_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/cea.12141","volume":"43","author":"R Agarwal","year":"2013","unstructured":"Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850\u201373.","journal-title":"Clin Exp Allergy"},{"key":"4027_CR11","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3109\/13693781003743148","volume":"48","author":"R Agarwal","year":"2010","unstructured":"Agarwal R, Hazarika B, Gupta D, et al. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol. 2010;48:988\u201394.","journal-title":"Med Mycol"},{"key":"4027_CR12","doi-asserted-by":"crossref","unstructured":"Jin J, Liu X, Sun Y. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function [J]. Respir Res. 2014;15:130.","DOI":"10.1186\/s12931-014-0130-1"},{"key":"4027_CR13","doi-asserted-by":"crossref","unstructured":"Tiew PY, Lim AYH, Keir HR et al. High frequency of allergic bronchopulmonary aspergillosis in Bronchiectasis-COPD overlap [J]. Chest. 2022;161(1):40\u201353.","DOI":"10.1016\/j.chest.2021.07.2165"},{"issue":"1","key":"4027_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4104\/pcrj.2012.00001","volume":"21","author":"E Mir","year":"2012","unstructured":"Mir E, Shah A. Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Prim Care Respir J. 2012;21(1):111\u20134.","journal-title":"Prim Care Respir J"},{"key":"4027_CR15","unstructured":"Liu XF, Sun YC, Jin JM et al. Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 3 cases [J]. Zhonghua Jie he he Hu Xi Za Zhi. 2013;36(10):741\u20135.\u00a0"},{"key":"4027_CR16","doi-asserted-by":"crossref","unstructured":"Tetikkurt C, Kubat B, Tetikkurt S et al. An atypical acute exacerbation of COPD due to Aspergillus fumigatus [J]. Monaldi Arch Chest Dis. 2020;90(1).","DOI":"10.4081\/monaldi.2020.1155"},{"key":"4027_CR17","unstructured":"Mengyu Wang YQ, Lin L, Wang H. Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 10 cases [J]. Zhonghua Jie he he Hu Xi Za Zhi. 2019;42(7):543\u20135."},{"key":"4027_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/COPD.S496521","volume":"20","author":"Y Luo","year":"2025","unstructured":"Luo Y, Ren J, Liang L, et al. Correlation of Aspergillus fumigatus sensitization with mucus plugging in COPD [J]. Int J Chron Obstruct Pulmon Dis. 2025;20:57\u201363.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4027_CR19","doi-asserted-by":"crossref","unstructured":"Agarwal R, Bhogal S, Choudhary H et al. Aspergillus sensitisation in Bidi smokers with and without chronic obstructive lung disease [J]. Mycoses. 2017;60(6):381\u20136.","DOI":"10.1111\/myc.12605"},{"key":"4027_CR20","doi-asserted-by":"crossref","unstructured":"Tiew PY, Narayana JK, Quek MSL et al. Sensitisation to Recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD [J]. Eur Respir J. 2023;61(1):2200507.","DOI":"10.1183\/13993003.00507-2022"},{"key":"4027_CR21","doi-asserted-by":"crossref","unstructured":"Tiew PY, Ko FWS, Pang SL et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD [J]. Eur respir J. 2020;56(2):2000418.","DOI":"10.1183\/13993003.00418-2020"},{"key":"4027_CR22","doi-asserted-by":"crossref","unstructured":"Lin L, Yi X, Liu H, et al. The airway Microbiome mediates the interaction between environmental exposure and respiratory health in humans [J]. Nat Med. 2023;29:1750\u20139.","DOI":"10.1038\/s41591-023-02424-2"},{"key":"4027_CR23","doi-asserted-by":"crossref","unstructured":"Muthu V, Kumar R, Prasad KT et al. Aspergillus sensitization in non-smokers versus smokers with chronic obstructive pulmonary disease [J]. Lung India. 2024;41:387\u201391.","DOI":"10.4103\/lungindia.lungindia_175_24"},{"key":"4027_CR24","doi-asserted-by":"crossref","unstructured":"Christenson SA, Smith BM, Bafadhel M, et al. Chronic Obstr Pulmonary Disease [J]. Lancet. 2022;399:2227\u201342.","DOI":"10.1016\/S0140-6736(22)00470-6"},{"key":"4027_CR25","doi-asserted-by":"crossref","unstructured":"Bouyssi A, Trecourt A, D\u00e9m\u00e9autis T, et al. Aspergillus fumigatus is responsible for inflammation in a murine model of chronic obstructive pulmonary disease exacerbation. Respir Res. 2025;26:25.","DOI":"10.1186\/s12931-024-03092-7"},{"key":"4027_CR26","doi-asserted-by":"crossref","unstructured":"Chen X, Zhi H, Wang X et al. Efficacy of biologics in patients with allergic bronchopulmonary aspergillosis: A systematic review and Meta-Analysis [J].Lung. 2024;202:367\u201383.","DOI":"10.1007\/s00408-024-00717-y"},{"key":"4027_CR27","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","volume":"377","author":"ID Pavord","year":"2017","unstructured":"Pavord ID, Chanez P, Criner GJ, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease [J]. N Engl J Med. 2017;377:1613\u201329.","journal-title":"N Engl J Med"},{"key":"4027_CR28","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","volume":"381","author":"GJ Criner","year":"2019","unstructured":"Criner GJ, Celli BR, Brightling CE, et al. Benralizumab for the prevention of COPD exacerbations [J]. N Engl J Med. 2019;381:1023\u201334.","journal-title":"N Engl J Med"},{"key":"4027_CR29","doi-asserted-by":"crossref","unstructured":"Singh D, Brightling CE, Rabe KF, et al. Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial. Lancet Respir Med. 2025;13(1):47\u201358.","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A7516"},{"key":"4027_CR30","doi-asserted-by":"crossref","unstructured":"Ogata H, Sha K, Kotetsu Y, et al. Tezepelumab treatment for allergic bronchopulmonary aspergillosis. Respirol Case Rep. 2023;11(5):e01147.","DOI":"10.1002\/rcr2.1147"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-04027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-04027-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-04027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:01:13Z","timestamp":1764943273000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-04027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4027"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-04027-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Clinical Research Ethics Committees of Peking University Third Hospital ((M2023784), and as it was a retrospective study, exemption from informed consent was applied.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"554"}}